University spinout signs agreement on Alzheimer's disease biomarkers

Press/Media: Research

Description

PharmaKure, a University of Manchester spinout company specialising in companion diagnostics for the treatment of neurological diseases, has launched a collaboration wth with  APIS Assay Technologies Ltd, a company with scientific expertise in biomarker translation, molecular diagnostics and bioinformatics.

Period3 Jul 2023

Media contributions

1

Media contributions

  • TitleUniversity spinout signs agreement on Alzheimer's disease biomarkers
    Degree of recognitionInternational
    Media name/outletUniversity of Manchester
    Media typeWeb
    Country/TerritoryUnited Kingdom
    Date3/07/23
    DescriptionPharmaKure, a University of Manchester spinout company specialising in companion diagnostics for the treatment of neurological diseases, has launched a collaboration wth with APIS Assay Technologies Ltd, a company with scientific expertise in biomarker translation, molecular diagnostics and bioinformatics.
    URLhttps://www.manchester.ac.uk/discover/news/university-spinout-signs-agreement-on-alzheimers-disease-biomarkers/
    PersonsAndrew Doig
View all 1
View less

Related content